Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.14309/ajg.0000000000000586 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Budd-Chiari Syndrome Management: Controversies and Open Issues.
Diagnostics (Basel)
November 2022
Centro di Riferimento Regionale Malattie Rare, Sindrome di Budd-Chiari e Teleangectasia Emorragica Ereditaria, Medicina Interna 1, ARNAS Civico-Di Cristina-Benfratelli, Piazzale Leotta 4, 90100 Palermo, Italy.
Budd-Chiari Syndrome (BCS) is due to thrombosis of hepatic veins (HVs), inferior vena cava (IVC) or both, leading to impaired hepatic venous outflow [...
View Article and Find Full Text PDFState of the Art, Current Perspectives, and Controversies of Budd-Chiari Syndrome: A Review.
J Clin Med Res
April 2022
Department of Hepato-Biliary and Liver Transplantation Surgery, Paul Brousse University Hospital, Paris-Saclay University, 94800 Villejuif, France.
Article Synopsis
- Budd-Chiari syndrome (BCS) involves conditions that block blood flow in the hepatic veins, with causes varying by region; thrombosis is common in the West while manifestations differ in Asia.
- A systematic review of 69 articles aimed to explore diverse treatment strategies due to the complexity and under-recognition of BCS internationally.
- Future research should focus on molecular pathways of thrombophilia, the impact of genetic factors on patient coagulation, and establishing a common prognostic index to better guide treatment decisions.
[Budd-Chiari syndrome, review and illustration].
Z Gastroenterol
September 2022
Allgemeine Innere Medizin (DAIM), Kliniken Beau Site, Salem und Permanence, Bern, Switzerland.
Budd-Chiari syndrome is a rare vascular disorder characterized by obstruction of the hepatic venous outflow. Various diseases causing coagulopathy play a role in aetiology, such as myeloproliferative disorders. Acute vascular occlusion may lead to acute phlebitis with fever.
View Article and Find Full Text PDFBudd-Chiari syndrome in Behçet's disease: a retrospective multicenter study.
Clin Rheumatol
January 2022
Department of Internal Medicine, Division of Rheumatology, Ondokuz Mayıs University School of Medicine, Samsun, Turkey.
Objective: To compare the clinical features, laboratory findings, and prognosis of Behçet's disease (BD) patients with and without Budd-Chiari syndrome (BCS).
Methods: This multicenter retrospective study investigated 61 (M/F: 41/20) patients with BD, having coexistent BCS, and 169 (M/F:100/69) BD patients as the control group without BCS from 22 different centers of Turkey diagnosed between 1990 and 2017.
Results: Of the total 61 BD patients with BCS, the onset of the first symptom and the median age of diagnosis were earlier in contrast to BD patients without BCS (p = 0.
Controversies in Budd-Chiari Syndrome Management: Potential Role of Liver Stiffness.
Am J Gastroenterol
June 2020
Medicina Interna 1, ARNAS Civico-Di Cristina-Benfratelli, Palermo, Italy.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!